Silodosin in the treatment of distal ureteric stones in children: A prospective, randomised, placebo-controlled study

Arab Journal of Urology
Hazem ElgalalyMostafa Kamel

Abstract

To evaluate the possible role of silodosin (a highly selective α1A-adrenoceptor antagonist) in facilitating the passage of distal ureteric stones (DUS) in children, as the role of α-blockers as medical expulsive therapy is well known in adults. In all, 40 paediatric patients (27 boys and 13 girls) diagnosed with unilateral, single, radiopaque DUS of <10 mm were included in the study. Their mean (SD, range) age was 8.1 (2.7, 5-17) years. The patients were randomly divided into two groups: Group A, received silodosin 4 mg as a single bedtime dose; and Group B, received placebo as a single bedtime dose. Ibuprofen was prescribed to both groups on-demand for pain episode relief. Patients were followed up biweekly for 4 weeks. The stone expulsion time and rate, pain episodes, analgesic use, and any adverse effects were recorded. The mean (SD) stone size in Group A was 6.6 (1.7) mm and in Group B was 6.7 (1.4) mm (P = 0.4). Two patients were lost to follow-up (one from each group), and one patient in Group A refused to complete the study. The stone-free rate at end of the 4-week treatment period was 88.8% in Group A vs 73.6% in Group B (P = 0.4). The mean (SD) stone expulsion time was 7.0 (4.3) vs 10.4 (4.7) days in groups A and B, re...Continue Reading

References

Mar 1, 1993·Mayo Clinic Proceedings·D S Milliner, M E Murphy
Mar 1, 1996·Urology·T D CohenG M Preminger
Feb 1, 1997·The Urologic Clinics of North America·R L Kroovand
Jan 1, 1997·World Journal of Urology·A Hesse, R Siener
Feb 14, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Víctor García-NietoNatalia Molini
May 15, 2003·Scandinavian Journal of Urology and Nephrology·Ahmet ErbagciKemal Sarica
Jun 14, 2006·Current Opinion in Urology·Douglas A Husmann
Jul 20, 2006·The Annals of Pharmacotherapy·Michele A Beach, Laurie S Mauro
Aug 8, 2007·Annals of Emergency Medicine·Amandeep SinghAmy Littlepage
Oct 23, 2009·The Journal of Urology·Ozgu AydogduTarkan Soygur
Aug 24, 2010·The Journal of Urology·Jonathan C RouthCaleb P Nelson
Nov 22, 2011·Journal of Pediatric Urology·Ibrahim MokhlessAhmed Fahmy
Aug 4, 2012·Pediatric Clinics of North America·Lawrence Copelovitch

❮ Previous
Next ❯

Citations

Jun 3, 2018·The Cochrane Database of Systematic Reviews·Lenka BarretoMarcin Kazmierski
Oct 10, 2019·The Cochrane Database of Systematic Reviews·Lenka BarretoMarcin Kazmierski

❮ Previous
Next ❯

Software Mentioned

SPSS
Statistical Package for Science ( SPSS®
Open Epi

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.